A comparison of letrozole and anastrozole followed by letrozole in breast cancer patients
Potchavit Aphinives, Damnern Vachirodom, Chaiyut Thanapaisal, Dhanes Rangsrikajee, Ongart SomintaraDepartment of Surgery, Faculty of Medicine, Khon Kaen University, Khon Kaen, ThailandBackground: We previously studied the noninferiority of anastrozole (ANZ) versus ANZ followed by letrozole (A-LTZ)...
Guardado en:
Autores principales: | Aphinives P, Vachirodom D, Thanapaisal C, Rangsrikajee D, Somintara O |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://doaj.org/article/f3af229ddbc44db2b571c9dec9745bff |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Effects of switching from anastrozole to letrozole, due to reimbursement policy, on the outcome of breast cancer therapy
por: Aphinives P, et al.
Publicado: (2014) -
Radiation recall dermatitis following letrozole administration in patient with a remote history of radiation therapy
por: Evan Sweren, et al.
Publicado: (2021) -
Clinical utility of the combination of lapatinib and letrozole in the management of hormone receptor-positive and HER2-positive advanced breast cancer
por: Merriam PA, et al.
Publicado: (2011) -
Surgery to Oligometastatic Breast Cancer after Excellent Response to Palbociclib and Letrozole Therapy: Pitfall of Ultrasound Therapeutic Evaluation
por: Suzuka Fujii, et al.
Publicado: (2021) -
Optimal delivery of male breast cancer follow-up care: improving outcomes
por: Ferzoco RM, et al.
Publicado: (2015)